Alexis Ogdie, MD, MSCE
Articles
July 20th 2021
Association of Physician Specialty With Psoriatic Arthritis Treatment and Costs
Ervant J. Maksabedian Hernandez, PhD, MPhil Joseph Tkacz, MS Nicole M. Zimmerman, MS Philip Chan, PhD, MS Brendan Limone, PharmD Alexis Ogdie, MD, MSCE Elaine Karis, MD Bradley Stolshek, PharmD
In this retrospective cohort study of patients with newly diagnosed psoriatic arthritis, the authors examine the association of treatment selection and costs with physician specialty.
August 13th 2020
Psoriatic Arthritis Treatment Patterns and Costs Among Pharmacologic Treatment–Naïve Patients
Ervant J. Maksabedian Hernandez, PhD Joseph Tkacz, MS Lorena Lopez-Gonzalez, PhD, MA Kate Higgins, MPH Alexis Ogdie, MD, MSCE Bradley S. Stolshek, PharmD
We present results of an analysis of IBM MarketScan databases that evaluates treatment patterns and health care costs for treatment-naïve patients with psoriatic arthritis.
Latest Updated Articles
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 20th 2024 | Updated: November 5th 2024
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
